Contura’s state-of-the-art manufacturing facility in Denmark has over 20 years of experience
producing 2.5 iPAAG* injectables. It is certified according to EU, US and other international
standards, using proprietary technology and stringent quality control measures to deliver
the highest quality products.
Solely dedicated to the production of 2.5 iPAAG, the facility uses proprietary automated processes to control manufacturing,
including the ALPH (Automated Line for Production of Hydrogel), a one-of-a-kind machine designed specifically for Contura.
ALPH’s advanced capabilities and design reflect our commitment to innovation and excellence in hydrogel production.
We have a team of highly qualified scientists and engineers who oversee the production process and ensure our syringes
are tightly monitored to meet release specifications.
Medical Device Certification
Our quality management system including product development
and manufacturing quality control procedures
are approved by the relevant international authorities.
These standards allow us to provide 2.5 iPAAG globally with distribution
in the UK, EU, USA, Canada, Australia and beyond.